Rasmus Sejersten Ripa

Rasmus Sejersten Ripa

Postdoc, Clinical Associate Professor


  1. Published

    Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial

    Ripa, Rasmus Sejersten, Jørgensen, E., Wang, Y., Thune, J. J., Nilsson, J. C., Søndergaard, Lars, Johnsen, H. E., Køber, Lars Valeur, Grande, P. & Kastrup, J., 2006, In: Circulation. 113, 16, p. 1983-92 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Labeling of Human Mesenchymal Stromal Cells with Indium-111 for SPECT Imaging

    Ripa, Rasmus Sejersten, Haack-Sørensen, M., Kastrup, J. & Ekblond, A., 2013, Encyclopedia of Metalloproteins. Uversky, V. N., Kretsinger, R. H. & Permyakov, E. A. (eds.). Springer, p. 1 1 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  3. Published

    Clinical outcome after stem cell mobilization with granulocyte-colony-stimulating factor after acute ST-elevation myocardial infarction: 5-year results of the STEMMI trial

    Ripa, Rasmus Sejersten, Jørgensen, E. & Kastrup, J., 2013, In: Scandinavian Journal of Clinical & Laboratory Investigation. 73, 2, p. 125-129

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. De novo mutations in familial adenomatous polyposis (FAP)

    Ripa, Rasmus Sejersten, Bisgaard, M. L., Bülow, S. & Nielsen, F. C., Oct 2002, In: European Journal of Human Genetics. 10, 10, p. 631-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease

    Ripa, Rasmus Sejersten, Wang, Y., Jørgensen, E., Johnsen, H. E., Hesse, B. & Kastrup, J., Aug 2006, In: European Heart Journal. 27, 15, p. 1785-92 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction-a magnetic resonance study

    Schoos, M. M., Munthe-Fog, L., Skjødt, Mikkel-Ole, Ripa, Rasmus Sejersten, Lønborg, Jacob Thomsen, Kastrup, J., Kelbæk, H., Clemmensen, P. & Garred, Peter, Jul 2013, In: Molecular Immunology. 54, 3-4, p. 408-14 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial

    Sejersten, M., Birnbaum, Y., Ripa, Rasmus Sejersten, Maynard, C., Wagner, G. S., Clemmensen, P. & DANAMI-2 Investigators, D. I., Nov 2006, In: Heart. 92, 11, p. 1577-82 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy

    Sejersten, M., Ripa, Rasmus Sejersten, Maynard, C., Grande, P., Andersen, H. R., Wagner, G. S., Clemmensen, P. & DANAMI-2 Investigators, D. I., Jul 2007, In: American Heart Journal. 154, 1, p. 61.e1-8

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial)

    Sejersten, M., Ripa, Rasmus Sejersten, Maynard, C., Wagner, G. S., Andersen, H. R., Grande, P., Mortensen, L. S. & Clemmensen, P., 1 Mar 2006, In: American Journal of Cardiology. 97, 5, p. 611-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

    Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642

    Research output: Contribution to journalLetterResearchpeer-review

ID: 45867987